Portal de Periódicos da CAPES

Liver transplantation for fulminant hepatic failure: importance of renal failure

1997; Springer Science+Business Media; Volume: 10; Issue: 1 Linguagem: Inglês

10.1111/j.1432-2277.1997.tb00537.x

1432-2277

Álvaro Caro Mendoza, Fernández Fernández F, David Mutimer,

Drug-Induced Hepatotoxicity and Protection

Abstract One hundred eighty-one consecutive patients with fulminant hepatic failure (FHF) presenting in a 2-year period were reviewed. In this cohort we examined the impact of pretransplant renal failure on mortality and morbidity following orthotopic liver transplantation (OLTx). Twenty-seven patients (18 female, 9 male) with a median age of 43.5 years (range 19–65 years) underwent OLTx. FHF was due to idiosyncratic drug reaction (n= 4), paracetamol overdose (n= 3), seronegative hepatitis (n= 17), hepatitis B (n= 1), veno-occlusive disease (n= 1), and Wilson's disease (n= 1). Renal failure was present in 14 patients, 7 of whom died (whereas there was 100 % survival in patients without renal failure). Pretransplant renal failure was associated with prolonged mechanical ventilation (13 days vs 6 days, P= 0.05), prolonged intensive care stay (17 days vs 8 days, P- 0.01) and prolonged hospital stay (27 vs 21 days, P= NS). Pretransplant renal failure did not predict renal dysfunction at 1 year after OLTx. We conclude that the survival of patients transplanted for FHF is inferior to that of patients transplanted for chronic liver disease (67 % vs 88 % 1-year survival in Birmingham). For patients with FHF undergoing transplantation, pretransplant renal failure strongly predicts poor outcome with significantly greater consumption of resources.